| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/20/1992 | EP0485381A1 Use of macrolactones as anti-allergy agents. |
| 05/20/1992 | CN1061153A Pharmaceutical composition and process for preparation of it |
| 05/19/1992 | US5114973 Method for treating autoimmune disease using succinylacetone |
| 05/19/1992 | US5114848 Prepared from bifidobacterium; immunomodulating properties |
| 05/19/1992 | US5114721 Lymphocytes activated by exposure to antigen and surface treated with photoactive psoralen crosslinking agent |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/19/1992 | CA1301181C2 Oxiranes |
| 05/19/1992 | CA1301179C 7-oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as "dual inhibitors" |
| 05/19/1992 | CA1301153C 3-(1h-tetrazol-5-yl)thieno(2,3-d)pyrimidin-4(3h)-ones |
| 05/19/1992 | CA1301151C 3,3-disubstituted indolines |
| 05/15/1992 | CA2055225A1 Compounds, pharmaceutical compositions containing them and process for preparing same |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007578A1 Use of protective agents against reactive oxygen species |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/13/1992 | EP0485232A1 Neovascularisation inhibitors |
| 05/13/1992 | EP0484936A1 Suspensions containing tricyclic compounds |
| 05/13/1992 | EP0484512A1 Human peripheral blood cells in an immunocompromised host |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/12/1992 | US5112988 Intermediates for Substance P Antagonists |
| 05/12/1992 | US5112836 Autoimmune diseases, antirheumatic agents and metabolic bone diseases |
| 05/12/1992 | US5112816 Corticorsteroid-containing ointments |
| 05/12/1992 | US5112811 Sdk peptides and therapeutic compositions containing them |
| 05/12/1992 | US5112810 Nonapeptides for thymic factor and multiple sclerosis treatment |
| 05/12/1992 | CA1300642C2 Eicosatetraynoic - 5,8,11,14 acid preparation process |
| 05/12/1992 | CA1300625C 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-[1]benzothieno [3,2-e]-1,2-thiazine-4-carboxamide-1,1-dioxides |
| 05/12/1992 | CA1300619C 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use |
| 05/12/1992 | CA1300612C Immunotherapeutic treatment |
| 05/09/1992 | CA2054983A1 Suspendible composition and process for preparing the same |
| 05/07/1992 | WO1992007567A1 Imidazolidinone compounds |
| 05/07/1992 | CA2095429A1 Imidazolidinone compounds |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0484223A2 3-Cycloalkylpropanamides, their tautomers and salts, process for their preparation, their use as medicaments and compositions containing them |
| 05/06/1992 | EP0484071A2 Synergism of HIV reverse transcriptase inhibitors |
| 05/06/1992 | EP0483842A1 Pharmaceutical compositions containing tricyclic compounds |
| 05/06/1992 | EP0483772A1 Aminocoumaran derivatives, their production and use |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0301006B1 Methylprednisolone/sodium carboxymethyl starch tablet composition |
| 05/06/1992 | CN1060848A Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising same |
| 05/06/1992 | CN1060846A Macrocyclic compounds |
| 05/06/1992 | CN1060841A Quinazol derivatives and there preparation |
| 05/06/1992 | CN1016508B Novel 16, 17-acetal substituted pregnane 21-oic acid derivatives |
| 05/05/1992 | US5110936 Condensation of pyroglutamic acid with ethyl ester of 4-thiazolidinecarboxylic acid |
| 05/05/1992 | US5110912 Purification of il-2-containing hybrid compounds |
| 05/05/1992 | US5110811 Antibody inhibitors |
| 05/05/1992 | US5110798 Purine derivatives having pharmacological action |
| 05/05/1992 | CA1300170C Process for intermediates to leukotriene antagonists |
| 05/05/1992 | CA1300169C Process for intermediates to leukotriene antagonists |
| 05/05/1992 | CA1300150C 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives |
| 05/02/1992 | WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2054529A1 Synergism of hiv reverse transcriptase inhibitors |
| 05/01/1992 | WO1992007581A1 Methods and compositions for suppressing allograft rejection in mammals |
| 04/30/1992 | WO1992007005A1 Platelet adhesion inhibitor |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006708A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 04/30/1992 | WO1992006704A1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 04/29/1992 | EP0482539A2 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/29/1992 | CN1060655A 4-or 5-substituled pyridine-2-carboxylic acids process for preparation thereof and use therof as pharmaceuticals |
| 04/29/1992 | CN1060653A Crystallization of optical isomers of leukotriene antagonists |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5108760 Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
| 04/25/1992 | CA2054097A1 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481673A2 Genes encoding the human FK-506 binding protein and a S. cerevisiae homolog, FKB1, and their expression |
| 04/22/1992 | EP0481522A1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/22/1992 | EP0481342A1 Quinazoline derivatives and their preparation |
| 04/22/1992 | EP0481311A2 Aminoacid derivatives |
| 04/22/1992 | CN1060474A Inhibitors for formation of tumor necrosis factor' processes for preparation thereof and use thereof |
| 04/22/1992 | CN1060464A 4,5-substituted pyridine-2-carboxylic acids, process for preparation thereof and use thereof as pharmaceuticals |
| 04/22/1992 | CN1016341B Novel spergualin-related compounds and process for producing the same |
| 04/21/1992 | US5106981 Skin disorders |
| 04/21/1992 | US5106858 For disfunction of heart, brain, lung or kidney |
| 04/21/1992 | US5106616 Administration of acemannan |
| 04/21/1992 | CA1299182C Eicosatetraynamides and their use in pharmaceutical and cosmetic products |
| 04/19/1992 | CA2053573A1 Amino acid derivatives |
| 04/18/1992 | WO1992006977A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 04/18/1992 | CA2071911A1 P-substituted derivatives of phenyl 4-oxybutane amine, processes for preparation thereof, and pharmaceutical compositions holding same |
| 04/16/1992 | WO1992006120A1 Antigen-antibody conjugates |
| 04/16/1992 | WO1992006108A1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof |
| 04/16/1992 | WO1992005793A1 Targeted immunostimulation with bispecific reagents |
| 04/16/1992 | CA2053475A1 Quinazoline derivatives and their preparation |
| 04/16/1992 | CA2052928A1 Genes encoding the human fk-506 binding protein and a.s. cerevisiae homolog, fkb1 and their expression |
| 04/15/1992 | EP0480717A1 Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/15/1992 | EP0480716A1 Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/15/1992 | EP0480713A1 Nucleoside antiviral and immunomodulating agents |
| 04/15/1992 | EP0480708A2 Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/1992 | EP0480623A1 New halomacrolides and derivatives having immunosuppressive activity |
| 04/15/1992 | EP0480455A1 Optically active thienotriazolodiazepine compounds |
| 04/15/1992 | EP0480389A1 Inhibitors for forming tumor necrosis factor, process for their production and their use |
| 04/15/1992 | EP0232328B1 Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters |
| 04/15/1992 | CN1060286A Antiinflammatory hydroxamic acids and n-hydroxyureas |
| 04/14/1992 | US5105020 Cycloalkane derivatives |
| 04/14/1992 | US5105017 Leukotriene antagonist intermediates |
| 04/14/1992 | US5104898 Administering succinylacetone(4,6-dioxoheptanoic acid) |
| 04/14/1992 | US5104889 Thiazole derivatives |
| 04/14/1992 | US5104861 7-oxoprostacyclin derivatives which are useful as pharmaceuticals |
| 04/14/1992 | CA1298839C Process for the preparation of dextrorotatory 3-)3-pyridyl-)1h,-pyrrolo(1,2-c) thiazole-7-carboxylic acid |